The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intestinal and tumor microbiome analysis combined with metabolomics of the anti-PD-L1 phase II PERFECT trial for resectable esophageal adenocarcinoma.
 
Nicolien C. de Clercq
No Relationships to Disclose
 
Tom van den Ende
No Relationships to Disclose
 
Andrei Prodan
No Relationships to Disclose
 
Mark I. van Berge Henegouwen
Consulting or Advisory Role - Johnson & Johnson (Inst); Medtronic (Inst); Mylan (Inst)
Research Funding - Olympus (Inst); Stryker (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson
 
Suzanne S. Gisbertz
No Relationships to Disclose
 
Sybren L. Meijer
No Relationships to Disclose
 
Sandor Schokker
Travel, Accommodations, Expenses - Roche
 
Jacques J.G.H.M. Bergman
No Relationships to Disclose
 
Nadia Haj Mohammad
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Lilly (Inst); MSD (Inst); SERVIER (Inst)
 
Jelle P. Ruurda
No Relationships to Disclose
 
Richard van Hillegersberg
No Relationships to Disclose
 
Stella Mook
No Relationships to Disclose
 
Nicole C.T. van Grieken
Consulting or Advisory Role - Merck Sharp & Dohme (Inst)
 
Tanja D. de Gruijl
Stock and Other Ownership Interests - lava therapeutics
Consulting or Advisory Role - DCPrime; Macrophage Pharma; Partner Therapeutics
Research Funding - Idera
Patents, Royalties, Other Intellectual Property - DCPrime; lava therapeutics
 
Mark Davids
No Relationships to Disclose
 
Maarten F. Bijlsma
Consulting or Advisory Role - SERVIER
Travel, Accommodations, Expenses - SERVIER
 
Maarten C.C.M. Hulshof
No Relationships to Disclose
 
Hanneke W.M. Van Laarhoven
Honoraria - Lilly/ImClone
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Nordic Group; Servier
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Max Nieuwdorp
No Relationships to Disclose